139 related articles for article (PubMed ID: 17670887)
1. Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy.
Spruill LS; Lowry AS; Stroud RE; Squires CE; Mains IM; Flack EC; Beck C; Ikonomidis JS; Crumbley AJ; McDermott PJ; Spinale FG
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1362-73. PubMed ID: 17670887
[TBL] [Abstract][Full Text] [Related]
2. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.
Spinale FG; Coker ML; Heung LJ; Bond BR; Gunasinghe HR; Etoh T; Goldberg AT; Zellner JL; Crumbley AJ
Circulation; 2000 Oct; 102(16):1944-9. PubMed ID: 11034943
[TBL] [Abstract][Full Text] [Related]
3. Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts.
Schram K; Wong MM; Palanivel R; No EK; Dixon IM; Sweeney G
J Mol Cell Cardiol; 2008 May; 44(5):874-81. PubMed ID: 18436234
[TBL] [Abstract][Full Text] [Related]
4. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
[TBL] [Abstract][Full Text] [Related]
5. Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia-reperfusion: relationship to interstitial microRNA dynamics and myocardial function.
Eckhouse SR; Akerman AW; Logdon CB; Oelsen JM; O'Quinn EC; Nadeau EK; Stroud RE; Mukherjee R; Jones JA; Spinale FG
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):267-275, 277.e1-4; discussion 275-7. PubMed ID: 23102905
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function.
Dixon JA; Gaillard WF; Rivers WT; Koval CN; Stroud RE; Mukherjee R; Spinale FG
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1947-58. PubMed ID: 20935147
[TBL] [Abstract][Full Text] [Related]
7. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.
Spinale FG; Mukherjee R; Zavadzkas JA; Koval CN; Bouges S; Stroud RE; Dobrucki LW; Sinusas AJ
J Biol Chem; 2010 Sep; 285(39):30316-27. PubMed ID: 20643648
[TBL] [Abstract][Full Text] [Related]
8. Alterations in membrane type-1 matrix metalloproteinase abundance after the induction of thoracic aortic aneurysm in a murine model.
Jones JA; Ruddy JM; Bouges S; Zavadzkas JA; Brinsa TA; Stroud RE; Mukherjee R; Spinale FG; Ikonomidis JS
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H114-24. PubMed ID: 20418476
[TBL] [Abstract][Full Text] [Related]
9. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
Spinale FG; Coker ML; Bond BR; Zellner JL
Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts.
Tyagi SC; Campbell SE; Reddy HK; Tjahja E; Voelker DJ
Mol Cell Biochem; 1996 Feb; 155(1):13-21. PubMed ID: 8717434
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.
Zile MR; Baicu CF; Stroud RE; Van Laer AO; Jones JA; Patel R; Mukherjee R; Spinale FG
Circ Heart Fail; 2014 Mar; 7(2):340-50. PubMed ID: 24395927
[TBL] [Abstract][Full Text] [Related]
12. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
13. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy.
Yokoseki O; Yazaki Y; Suzuki J; Imamura H; Takenaka H; Isobe M
Jpn Circ J; 2000 May; 64(5):352-7. PubMed ID: 10834450
[TBL] [Abstract][Full Text] [Related]
14. Regulation of membrane type-1 matrix metalloproteinase activity and intracellular localization in clinical thoracic aortic aneurysms.
Ikonomidis JS; Nadeau EK; Akerman AW; Stroud RE; Mukherjee R; Jones JA
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):537-546. PubMed ID: 27923483
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
16. Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling.
Zavadzkas JA; Mukherjee R; Rivers WT; Patel RK; Meyer EC; Black LE; McKinney RA; Oelsen JM; Stroud RE; Spinale FG
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1656-66. PubMed ID: 21666120
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging.
Spinale FG; Escobar GP; Mukherjee R; Zavadzkas JA; Saunders SM; Jeffords LB; Leone AM; Beck C; Bouges S; Stroud RE
Circ Heart Fail; 2009 Jul; 2(4):351-60. PubMed ID: 19808359
[TBL] [Abstract][Full Text] [Related]
18. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.
Tellier E; Nègre-Salvayre A; Bocquet B; Itohara S; Hannun YA; Salvayre R; Augé N
Mol Cell Biol; 2007 Apr; 27(8):2997-3007. PubMed ID: 17283058
[TBL] [Abstract][Full Text] [Related]
19. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration.
Schram K; Ganguly R; No EK; Fang X; Thong FS; Sweeney G
Endocrinology; 2011 May; 152(5):2037-47. PubMed ID: 21385940
[TBL] [Abstract][Full Text] [Related]
20. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
